Gland Pharma’s Hyderabad Facility Receives Establishment Inspection Report From USFDA

The company’s earnings before interest, tax, depreciation and amortisation slipped to Rs 297.06 crore, down 8%, for the July-September quarter of the current fiscal 2025 as against Rs 324.08 crore for the same quarter in the previous financial year 2024.

Margins narrowed at 21.1% for the three months ended Sept. 30, 2024, as against 23.6% for the same quarter last year.

Shares of Gland Pharma closed 0.20% higher at Rs 1,679.20 apiece on the National Stock Exchange, compared to a 0.47% fall in the benchmark Nifty. The share price has fallen 13.09% in the last 12 months.

Out of 16 analysts tracking the company, eight maintain a ‘buy’ rating on the stock, one recommends ‘hold,’ and seven suggest ‘sell,’ according to Bloomberg data. The average of 12-month analysts’ price targets implies a potential upside of 16.1%.

  • Related Posts

    Operation Monsoon Thunder: NCB raids four cities, arrests six in probe into US-bound opioid and psychotropic drug shipments

    New Delhi: In a sweeping international crackdown, the Narcotics Control Bureau (NCB) and the US Drug Enforcement Administration (DEA) have dismantled the Indian nerve center of a massive transnational drug…

    Maharashtra FDA issues statewide compliance order for health supplements, nutraceuticals

    Commissioner of Food Safety Tukaram Mundhe said inspections, consumer complaints and surveillance had repeatedly revealed violations Repeated violations of existing food safety regulations by manufacturers and sellers of health supplements…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Operation Monsoon Thunder: NCB raids four cities, arrests six in probe into US-bound opioid and psychotropic drug shipments

    Operation Monsoon Thunder: NCB raids four cities, arrests six in probe into US-bound opioid and psychotropic drug shipments

    Maharashtra FDA issues statewide compliance order for health supplements, nutraceuticals

    Maharashtra FDA issues statewide compliance order for health supplements, nutraceuticals

    Karnataka High Court quashes case against MedPlus over short supply of one tablet costing ₹1.12

    Karnataka High Court quashes case against MedPlus over short supply of one tablet costing ₹1.12

    Fake epilepsy, diabetes drugs made using chalk, lactose at illegal Himachal factory; 2 held

    Fake epilepsy, diabetes drugs made using chalk, lactose at illegal Himachal factory; 2 held

    Without Skipping a Beat: Surgical Robot SSiMantra powers Landmark Beating Heart Bypass

    Without Skipping a Beat: Surgical Robot SSiMantra powers Landmark Beating Heart Bypass

    Drug Department Raids Patna’s Govind Mitra Road Medicine Market Over Suspected Illegal Sale Of Medicines

    Drug Department Raids Patna’s Govind Mitra Road Medicine Market Over Suspected Illegal Sale Of Medicines